A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for […]
Abstract Iconicity is a relationship of resemblance between the form and meaning of a sign. Compelling evidence from diverse areas of the cognitive sciences suggests that iconicity plays a pivotal role in the processing, memory, learning, and evolution of both spoken and signed language, indicating that iconicity is a general property of language. However, the […]
Having a successful, stress-free holiday season starts with taking care of yourself, Dr. Jeff Gardere told Newsmax Wednesday. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of […]
© 2025 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.